HUTCHMED (China) HCM
NASDAQ HCM
$12.63 +0.07 (+0.56%)
At close: Aug 21, 2026 · 4:00 PM EDT

HUTCHMED (China) (HCM) Cash & Current Investments (2014 - 2026)

HUTCHMED (China) (HCM) posted quarterly Cash & Current Investments of $1.4 billion for Q2 2026, up 0.75% year-over-year from $1.4 billion in Q2 2025, and up 682.04% quarter-over-quarter from $175.8 million in Q4 2025.

HUTCHMED (China) (HCM) Cash & Current Investments (2014 - 2026) Analysis & Trends

HUTCHMED (China) (HCM) has reported Cash & Current Investments for 13 consecutive years, with $1.4 billion the latest figure, recorded in Q2 2026.

  • In Q2 2026, Cash & Current Investments rose 0.75% year-over-year to $1.4 billion; the TTM figure through Jun 2026 stood at $1.4 billion (up 0.75% YoY), while the FY2025 annual figure was $175.8 million, up 64.06% from the prior year.
  • Cash & Current Investments improved to $1.4 billion in Q2 2026 per HCM's latest filing, from $175.8 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $1.4 billion in Q2 2026 and bottomed at $113433.7 in Q4 2023.
  • Historically, Cash & Current Investments has averaged $620.9 million across 5 years, with a median of $802.5 million in 2024.
  • Annual changes were most pronounced in 2023 — Cash & Current Investments tumbled 99.86% — and 2024, when it jumped 94712.72%.
  • HUTCHMED (China)'s Cash & Current Investments stood at $80.7 million in 2022, then plunged by 99.86% to $113433.7 in 2023, then surged by 94712.72% to $107.5 million in 2024, then soared by 63.46% to $175.8 million in 2025, then jumped by 682.04% to $1.4 billion in 2026.
  • Business Quant data shows HCM's Cash & Current Investments at $1.4 billion in Q2 2026, $175.8 million in Q4 2025, and $1.4 billion in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 963.33 Mn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 3.66 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 1.68 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 5.80 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 2.66 Bn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 886.50 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 389.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 530.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 164.00 Mn
10 HUTCHMED (China) 2.19 Bn 2.19 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2026 1.37 Bn
Dec 31, 2025 175.80 Mn
Jun 30, 2025 1.36 Bn
Dec 31, 2024 107.55 Mn
Jun 30, 2024 802.45 Mn
Dec 31, 2023 113,433.74
Jun 30, 2023 856.17 Mn
Dec 31, 2022 80.67 Mn
Jun 30, 2022 826.20 Mn
Dec 31, 2021 129.88 Mn
Jun 30, 2021 950.45 Mn
Mar 31, 2021 396.07 Mn
Dec 31, 2020 435.18 Mn
Jun 30, 2020 281.01 Mn
Dec 31, 2019 217.17 Mn
Sep 30, 2019 201.58 Mn
Jun 30, 2019 237.29 Mn
Mar 31, 2019 271.86 Mn
Dec 31, 2018 300.95 Mn
Jun 30, 2018 322.49 Mn